Substantial Clinical Trials Market in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Substantial Clinical Trials Market in Colombia

Substantial Clinical Trials Market in Colombia – Clinical Trials in LATAM

Clinical trials serve as the cornerstone of medical progress, propelling innovative treatments from lab bench to patient bedside. In this context, Colombia has emerged as a significant contender in the global clinical trials market.

With a robust healthcare infrastructure, a diverse patient pool, and an evolving regulatory framework, Colombia presents a promising landscape for clinical research. This blog explores the substantial clinical trials market in Colombia, shedding light on its key characteristics, benefits, challenges, and future potential.

The Colombian Clinical Trials Landscape

Colombia’s clinical trials sector has undergone remarkable growth, earning recognition as a valuable destination for both domestic and international pharmaceutical and biotechnology companies seeking to conduct trials. The nation’s strategic location, coupled with a supportive regulatory environment, has positioned it as a hub for cutting-edge medical research.

Advantages of Conducting Clinical Trials in Colombia

  1. Diverse Patient Population: Colombia’s population showcases a wide genetic diversity and includes various ethnic backgrounds. This diversity is advantageous for clinical trials aiming to assess treatment efficacy across different genetic profiles.
  2. Cost-Effectiveness: Conducting clinical trials in Colombia is often more cost-effective than in developed countries due to factors such as lower operational costs and reduced expenses related to infrastructure and personnel.
  3. Experienced Researchers: The country boasts a pool of skilled healthcare professionals and researchers with experience in diverse therapeutic areas. This expertise ensures the smooth execution of trials and the generation of high-quality data.

Accelerated Enrollment: Colombia’s patient enrollment rates are often faster compared to more saturated markets, enabling quicker recruitment.

Substantial Clinical Trials Market in Colombia

Substantial Clinical Trials Market in Colombia

Substantial Clinical Trials Market in Colombia

Challenges in the Clinical Trials Market

While Colombia offers numerous advantages, several challenges need to be addressed to fully harness its potential:

  1. Regulatory Complexity: Navigating the regulatory landscape can be intricate, with varying requirements and processes. Harmonization of regulations is crucial for streamlining trial initiation and execution.
  2. Infrastructure Gaps: Urban centers in Colombia possess well-equipped medical facilities, but rural areas might lack necessary infrastructure. Bridging this gap ensures broader patient accessibility.
  3. Language and Cultural Barriers: Effective communication with participants is vital for trial success. Language and cultural differences could pose challenges in obtaining informed consent and maintaining participant engagement.
  4. Data Quality and Security: Maintaining data integrity and security is paramount for reliable research outcomes. Investments in data management systems and cybersecurity are imperative.

Future Prospects and Opportunities

The future of Colombia’s clinical trials market is promising, with increasing government initiatives, regulatory advancements, and infrastructure development. The country’s participation in international research networks further enhances its global recognition and credibility.

To seize these opportunities, Colombia must address its challenges proactively. Continued efforts to streamline regulations, enhance healthcare accessibility, and bridge urban-rural healthcare disparities will foster an environment conducive to innovative research.

Expanding Horizons: Collaborations and Innovations

Colombia’s clinical trials market has also witnessed a surge in international collaborations and partnerships. Pharmaceutical and biotech companies are increasingly recognizing the value of tapping into Colombia’s expertise and resources for their research endeavors. These collaborations not only bring cutting-edge treatments to Colombian patients but also contribute to the global pool of medical knowledge.

One noteworthy aspect of Colombia’s clinical trials landscape is its emphasis on innovative research areas. While traditional therapeutic areas like oncology and cardiology remain prominent, Colombia is also exploring novel fields such as regenerative medicine, biotechnology, and personalized medicine.

This diversification not only showcases Colombia’s willingness to embrace new scientific frontiers but also positions it as a pioneer in advancing medical breakthroughs.


Colombia’s ascent in the clinical trials market is marked by its exceptional advantages and proactive strides. The nation’s diverse patient pool, cost-effectiveness, expert researchers, and improving regulatory landscape position it as a key player in global clinical research. While obstacles exist, they can be surmounted through collaborative efforts.

By enhancing regulations, bolstering healthcare infrastructure, and prioritizing data integrity, Colombia can solidify its role as a substantial contributor to medical advancements. As the country continues its journey of growth and transformation, its contributions to clinical research are poised to have a lasting impact on the global healthcare landscape.

Substantial Clinical Trials Market in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Substantial Clinical Trials Market in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Substantial Clinical Trials Market in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Substantial Clinical Trials Market in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Substantial Clinical Trials Market in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Substantial Clinical Trials Market in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Substantial Clinical Trials Market in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Substantial Clinical Trials Market in Colombia

The Cohortias Team

Substantial Clinical Trials Market in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Substantial Clinical Trials Market in Colombia

Network & Partnerships